Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

Story

Baiaogeometry Raises A+ Round as A-Series Funding Tops $100M

AI summary

AI-native biopharmaceutical company Baiaogeometry announced an A+ financing round led by Guoshou Capital, with Shanghai Biopharmaceutical Fund increasing its investment and other firms participating. According to 36氪, the company’s cumulative A-series funding now exceeds US$100 million. The proceeds are earmarked for iterating the GeoFlow molecular-level and GeoCell cell-level world models, expanding high-throughput automated laboratories, and commercializing its proprietary drug pipeline.

In-depth insight

The financing provides substantial reported backing for Baiaogeometry’s AI world models, laboratory automation, and drug-pipeline commercialization, making it a notable AI-for-science funding event.

#Baiaogeometry#GeoFlow#GeoCell#Guoshou Capital#Shanghai Biopharmaceutical Fund#CDB Sci-Tech#Ruili Investment#Guofang Venture Capital#Fortune Capital#Index Capital

Original · 3 min readRead the original
Group chat

No comments yet. Start the conversation.